184 related articles for article (PubMed ID: 26611583)
1. Viral Vector Production: Adenovirus.
Kim JW; Morshed RA; Kane JR; Auffinger B; Qiao J; Lesniak MS
Methods Mol Biol; 2016; 1382():115-30. PubMed ID: 26611583
[TBL] [Abstract][Full Text] [Related]
2. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
Lie-A-Ling M; Bakker CT; Wesseling JG; Bosma PJ
Gene Ther; 2005 Sep; 12(17):1347-52. PubMed ID: 15877046
[TBL] [Abstract][Full Text] [Related]
3. Targeted gene delivery by tropism-modified adenoviral vectors.
Douglas JT; Rogers BE; Rosenfeld ME; Michael SI; Feng M; Curiel DT
Nat Biotechnol; 1996 Nov; 14(11):1574-8. PubMed ID: 9634824
[TBL] [Abstract][Full Text] [Related]
4. Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.
Nettelbeck DM; Rivera AA; Kupsch J; Dieckmann D; Douglas JT; Kontermann RE; Alemany R; Curiel DT
Int J Cancer; 2004 Jan; 108(1):136-45. PubMed ID: 14618628
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K
Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547
[TBL] [Abstract][Full Text] [Related]
6. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators.
Mowa MB; Crowther C; Arbuthnot P
Expert Opin Drug Deliv; 2010 Dec; 7(12):1373-85. PubMed ID: 21073358
[TBL] [Abstract][Full Text] [Related]
8. Localized adenovirus gene delivery using antiviral IgG complexation.
Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
[TBL] [Abstract][Full Text] [Related]
9. Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors.
Douglas JT; Curiel DT
Neuromuscul Disord; 1997 Jul; 7(5):284-98. PubMed ID: 9267842
[TBL] [Abstract][Full Text] [Related]
10. Vector systems for prenatal gene therapy: principles of adenovirus design and production.
Alba R; Baker AH; Nicklin SA
Methods Mol Biol; 2012; 891():55-84. PubMed ID: 22648768
[TBL] [Abstract][Full Text] [Related]
11. Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectors.
Pereboeva L; Komarova S; Mahasreshti PJ; Curiel DT
Virus Res; 2004 Sep; 105(1):35-46. PubMed ID: 15325079
[TBL] [Abstract][Full Text] [Related]
12. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.
Renaut L; Colin M; Leite JP; Benko M; D'Halluin JC
Virology; 2004 Apr; 321(2):189-204. PubMed ID: 15051380
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus receptors: implications for targeting of viral vectors.
Arnberg N
Trends Pharmacol Sci; 2012 Aug; 33(8):442-8. PubMed ID: 22621975
[TBL] [Abstract][Full Text] [Related]
14. Manufacturing of adenovirus vectors: production and purification of helper dependent adenovirus.
Dormond E; Kamen AA
Methods Mol Biol; 2011; 737():139-56. PubMed ID: 21590396
[TBL] [Abstract][Full Text] [Related]
15. Strategies to adapt adenoviral vectors for targeted delivery.
Curiel DT
Ann N Y Acad Sci; 1999; 886():158-71. PubMed ID: 10667212
[TBL] [Abstract][Full Text] [Related]
16. Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein.
Sauthoff H; Pipiya T; Heitner S; Chen S; Norman RG; Rom WN; Hay JG
Hum Gene Ther; 2002 Oct; 13(15):1859-71. PubMed ID: 12396618
[TBL] [Abstract][Full Text] [Related]
17. Neurotropism and retrograde axonal transport of a canine adenoviral vector: a tool for targeting key structures undergoing neurodegenerative processes.
Peltékian E; Garcia L; Danos O
Mol Ther; 2002 Jan; 5(1):25-32. PubMed ID: 11786042
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.
Haisma HJ; Pinedo HM; Rijswijk A; der Meulen-Muileman I; Sosnowski BA; Ying W; Beusechem VW; Tillman BW; Gerritsen WR; Curiel DT
Gene Ther; 1999 Aug; 6(8):1469-74. PubMed ID: 10467371
[TBL] [Abstract][Full Text] [Related]
19. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.
Smith TA; Idamakanti N; Marshall-Neff J; Rollence ML; Wright P; Kaloss M; King L; Mech C; Dinges L; Iverson WO; Sherer AD; Markovits JE; Lyons RM; Kaleko M; Stevenson SC
Hum Gene Ther; 2003 Nov; 14(17):1595-604. PubMed ID: 14633402
[TBL] [Abstract][Full Text] [Related]
20. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
